Agilent Technologies (A) Tops Q3 EPS by 6c; revises guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
Agilent (A) PT Raised to $147 at BofA Securities
August 22, 2024 6:21 AM EDTBofA Securities analyst Derik de Bruin raised the price target on Agilent (NYSE: A) to $147.00 (from $140.00) while maintaining a Neutral rating.
The analyst comments "We update our forecasts, driving our PO to $147 (from $140), based on 20x CY25E Adj EBITDA vs 19x previously,... More
Agilent (A) PT Raised to $135 at Evercore ISI
August 22, 2024 5:17 AM EDTEvercore ISI analyst Vijay Kumar raised the price target on Agilent (NYSE: A) to $135.00 (from $130.00) while maintaining a In Line rating.
The analyst comments "A reported total revs of $1.578M (org decline of -4.5%), which came in ~130 bps above ST. The slightly better rev performance was driven by pharma (declined -8%) coming in slightly better, China (declined - 11%) a tad better and NASD inline with expecs (revs declined QoQ as expected). Relative to EVRe, a better biopharma, Dx & Environmental performance was partly offset by Food & Chemical end mkts coming in below.... More
Agilent (A) PT Raised to $165 at Citi
August 22, 2024 4:57 AM EDTCiti analyst Patrick Donnelly raised the price target on Agilent (NYSE: A) to $165.00 (from $150.00) while maintaining a Buy rating.
The analyst comments "Agilent reported a F3Q24 organic decline of (4.4%) ahead of guidance of (6.9%)-(4.5%) with adj. EPS of $1.32 above guidance of $1.25-1.28... More



